VIMIZIM (elosulfase alfa)

**Product type:** Human Prescription Drug

**Active ingredient:** ELOSULFASE ALFA

**Strength:** 5 mg/5mL

**Dosage form:** Injection, Solution, Concentrate

**Route:** Intravenous

**Labeler:** BioMarin Pharmaceutical Inc.

**Marketing category:** BLA (BLA125460)

**Pharmacologic class:** Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC], alpha-Glucosidases [CS]